NFKB1 and cardiac hypertrophy: To further confirm that Bak attenuates cardiac hypertrophy by mediating the NF-κB signaling pathway, we pretreated NRCMs with a selective NF-κB inhibitor, PDTC, for 1 h and then with Ang II for 48 h, after treatment with Bak for 24 h.